Back to News
Market Impact: 0.35
Healthcare software firm Waystar explores options including sale, sources say
Source: reuters.com
M&A & RestructuringHealthcare & BiotechFintech

Waystar, a healthcare payments software provider, is exploring strategic options including a potential sale that could take it private roughly two years after its New York stock-market listing. The reported process could affect Waystar’s valuation and shares, but no prospective buyer, transaction value, or timeline was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
WAY0.15
More News
- Illumina CEO on Q3 Results and Business Outlook
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Exxon Increases Stake in Mozambique Gas Project Via Eni Swap
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand